Citations

Clear

1011 citation(s) found for "Barry, WT".

Evaluation of Primary Care Patients with Chronic Stable Angina: Guidelines from the American College of Physicians
Snow, Vincenza , Barry, Patricia P., Fihn, Stephan D., Gibbons, Raymond J. , Owens, Douglas K, Williams, Sankey V. , Weiss, Kevin B. , Mottur-Pilson, Christel, Panel*, and the ACP/ACC Chronic Stable Angina, Panel*, and the ACP/ACC Chronic Stable Angina

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 141 | Issue: 1 | Pages: 57-64

10.7326/0003-4819-141-1-200407060-00015 | PMID 15238371 Get It

Diabetic Neuropathy and HLA-DR3/4
Heise, Eugene R., Canzanello, Vincent J., Freedman, Barry I.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 117 | Issue: 5 | Pages: 445-445

10.7326/0003-4819-117-5-445_1 | PMID 1503344 Get It

Contemporary Ventilator Management in Patients With and at Risk of ALI/ARDS
Chang, Steven Y., Dabbagh, Ousama, Gajic, O, Patrawalla, Amee , Elie, Marie‐Carmelle , Talmor, Daniel , Malhotra, Atul , Adesanya, Adebola, Anderson, Harry L, Blum, James M. , Park, Pauline K. , Gong, Michelle N. , (USCIITG-LIPS), on behalf of the United States Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators, (USCIITG-LIPS), the United States Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators, Talmor, Daniel S, Bender, S Patrick, Garcia, Mauricio, Hou, Peter C, Barry, Jonathan M, Shempp, Iam, Malhotra, Atul, Frendl, Gyorgy, Ahmed, Adil, Gajic, Ognjen, Malinchoc, Michael, Kor, Daryl J, Afessa, Bekele, Cartin-Ceba, Rodrigo, Gong, Michelle Ng, Gentile, Nina T, Stevenson, Karen, Freeman, Brent, Srinivasan, Sujatha, Sevransky, Jonathan, Chang, Steven Y, Patrawalla, Amee, Elie, Carmelle, Hamdani, Irram, Seiden, Jason, Douglas, Ivor, Mikkelsen, Mark, Christie, Jason D, Gaieski, David F, Lanken, Paul, Meyer, Nuala, Sha, Chirag, Park, Pauline K, Harris, Julie, Napolitano, Lena, Raghavendran, Krishnan, Hyzy, Robert C, Blum, James, Watkins, Timothy R, Deem, Steven, Treggiari, Miriam, Adesanya, Adebola, Sadikot, Ruxana, Hoth, J Jason, Yoza, Barbara, Festic, Emir, Kaufman, David, Bajwa, Ednan, Malhotra, Atul, Thompson, B Taylor, Christiani, David C, Cengiz, Melike, Yilmaz, Murat, Anderson, Harry, Tchorz, Kathryn, McCarthy, Mary C, Uddin, David, Iscimen, Remzi, Dabbagh, Ousama, Kallenbach, Nena, Esper, Anette, Martin, Greg, Bajwa, Ednan K. , Douglas, Ivor S. , Frendl, György , Chang, Steven Y. , Anderson, Harry L, (USCIITG-LIPS), on behalf of the United States Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators, (USCIITG-LIPS), the United States Critical Illness and Injury Trials Group: Lung Injury Prevention Study Investigators, Talmor, Daniel S, Bender, S Patrick, Garcia, Mauricio, Hou, Peter C, Barry, Jonathan M, Shempp, Iam, Malhotra, Atul, Frendl, Gyorgy, Ahmed, Adil, Gajic, Ognjen, Malinchoc, Michael, Kor, Daryl J, Afessa, Bekele, Cartin-Ceba, Rodrigo, Gong, Michelle Ng, Gentile, Nina T, Stevenson, Karen, Freeman, Brent, Srinivasan, Sujatha, Sevransky, Jonathan, Chang, Steven Y, Patrawalla, Amee, Elie, Carmelle, Hamdani, Irram, Seiden, Jason, Douglas, Ivor, Mikkelsen, Mark, Christie, Jason D, Gaieski, David F, Lanken, Paul, Meyer, Nuala, Sha, Chirag, Park, Pauline K, Harris, Julie, Napolitano, Lena, Raghavendran, Krishnan, Hyzy, Robert C, Blum, James, Watkins, Timothy R, Deem, Steven, Treggiari, Miriam, Adesanya, Adebola, Sadikot, Ruxana, Hoth, J Jason, Yoza, Barbara, Festic, Emir, Kaufman, David, Bajwa, Ednan, Malhotra, Atul, Thompson, B Taylor, Christiani, David C, Cengiz, Melike, Yilmaz, Murat, Anderson, Harry, Tchorz, Kathryn, McCarthy, Mary C, Uddin, David, Iscimen, Remzi, Dabbagh, Ousama, Kallenbach, Nena, Esper, Anette, Martin, Greg

Mayo Clinic

Respiratory Care | April 6, 2013 | Volume: 58 | Issue: 4 | Pages: 578-588

10.4187/respcare.01755 | PMID 22906363 Get It

Histopathologic Variability in Usual and Nonspecific Interstitial Pneumonias
FLAHERTY, KEVIN R., Colby, Thomas V. , Toews, Galen B., Kazerooni, Ella A. , Gross, Barry H., Strawderman, Robert L. , Flint, Andrew , Lynch, Joseph P., FLAHERTY, KEVIN R., Travis, William D. , Jain, Arvind Kumar , Martínez, Fernando J.

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 164 | Issue: 9 | Pages: 1722-1727

10.1164/ajrccm.164.9.2103074 | PMID 11719316 Get It

Abstract Findings of surgical lung biopsy (SLB) are important in categorizing patients with idiopathic interstitial pneumonia (IIP). We investigated whether histologic variability would be evident in SLB specimens from multiple lobes in patients with IIP. SLBs from 168 patients, 109 of whom had multiple lobes biopsied, were reviewed by three pathologists. A diagnosis was assigned to each lobe. A different diagnosis was found between lobes in 26% of the patients. Patients with usual interstitial pneumonia (UIP) in all lobes were categorized as concordant for UIP (n = 51) and those with UIP in at least one lobe were categorized as discordant for UIP (n = 28). Patients with nonspecific interstitial pneumonia (NSIP) in all lobes were categorized as having fibrotic (n = 25) or cellular NSIP (n = 5). No consistent distribution of lobar histology was noted. Patients concordant for UIP were older (63 ± 9 [mean ± SD] yr; p < 0.05 as compared with all other groups) than those discordant for UIP (57 ± 12 yr) or with fibrotic NSIP (56 ± 11 yr) or cellular NSIP (50 ± 9 yr). Semiquantitative high-resolution computed tomography demonstrated a varied profusion of fibrosis (p < 0.05 for all group comparisons), with more fibrosis in concordant UIP (2.13 ± 0.62) than in discordant UIP (1.42 ± 0.73), fibrotic NSIP (0.83 ± 0.58), or cellular NSIP (0.44 ± 0.42). Survival was better for patients with NSIP than for those in both UIP groups (p < 0.001), although survival in the two UIP groups was comparable (p = 0.16). Lobar histologic variability is frequent in patients with IIP, patients with a histologic pattern of UIP in any lobe should be classified as having UIP.
Utility of a Lung Biopsy for the Diagnosis of Idiopathic Pulmonary Fibrosis
Hunninghake, Gary W., Zimmerman, M. Bridget, King, Talmadge E. , Lynch, Joseph P., Hegele, Richard G. , Waldron, James A., Colby, Thomas V. , Müller, Néstor L. , Lynch, David A. , Galvin, J R, Gross, Barry H., Hogg, James C. , Toews, Galen, HELMERS, RICK, COOPER, J. ALLEN D., Baughman, Robert P., Millard, Mark, Schwartz, David A. , HELMERS, RICK, Strange, Charlie

Mayo Clinic

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 164 | Issue: 2 | Pages: 193-196

10.1164/ajrccm.164.2.2101090 | PMID 11463586 Get It

Abstract It is not known if a surgical lung biopsy is necessary in all patients for the diagnosis of idiopathic pulmonary fibrosis (IPF). We conducted a blinded, prospective study at eight referring centers. Initially, cases were evaluated by clinical history and examination, transbronchial biopsy, and high-resolution lung computed tomography scans. Pulmonologists at the referring centers then assessed their certainty of the diagnosis of IPF and provided an overall diagnosis, before surgical lung biopsy. The lung biopsies were reviewed by a pathology core and 54 of 91 patients received a pathologic diagnosis of IPF. The positive predictive value of a confident (certain) clinical diagnosis of IPF by the referring centers was 80%. The positive predictive value of a confident clinical diagnosis was higher, when the cases were reviewed by a core of pulmonologists (87%) or radiologists (96%). Lung biopsy was most important for diagnosis in those patients with an uncertain diagnosis and those thought unlikely to have IPF. These studies suggest that clinical and radiologic data that result in a confident diagnosis of IPF by an experienced pulmonologist or radiologist are sufficient to obviate the need for a lung biopsy. Lung biopsy is most helpful when clinical and radiologic data result in an uncertain diagnosis or when patients are thought not to have IPF.
Brief Report: Rheumatoid Arthritis Is Associated With Left Ventricular Concentric Remodeling: Results of a Population‐Based Cross‐Sectional Study
Davis, John M. , Crowson, Cynthia S. , Roger, Véronique L. , Karon, Barry L., Borgeson, Daniel D., Therneau, Terry M. , Matteson, Eric L. , Rodeheffer, Richard J. , Gabriel, Sherine E., Myasoedova, Elena , Davis, John M

Mayo Clinic

Arthritis & Rheumatism | April 1, 2013 | Volume: 65 | Issue: 7 | Pages: 1713-1718

10.1002/art.37949 | PMID 23553738 Get It

ObjectiveTo study left ventricular (LV) geometry in patients with rheumatoid arthritis (RA) and no history of heart failure compared with that in subjects with neither RA nor a history of heart failure, and to determine the impact of RA on LV remodeling.MethodsA cross‐sectional, community‐based study was conducted among adult (age ≥50 years) patients with RA and age‐ and sex‐matched subjects with neither RA nor a history of heart failure. All participants underwent standard 2‐dimensional Doppler echocardiography. LV geometry was classified into the following 4 categories based on relative wall thickness and sex‐specific cutoffs for the LV mass index: concentric remodeling, concentric hypertrophy, eccentric hypertrophy, or normal geometry.ResultsAmong 200 patients with RA and 600 age‐ and sex‐matched subjects without RA, the mean age was 65 years, and 74% of the individuals in both cohorts were female. Compared with subjects without RA, patients with RA were significantly more likely to have abnormal LV geometry (odds ratio [OR] 1.44, 95% confidence interval [95% CI] 1.03–2.00), even after adjusting for cardiovascular risk factors and comorbidities. Among subjects with abnormal LV geometry, the odds of concentric LV remodeling were significantly increased in patients with RA (OR 4.73, 95% CI 2.85–7.83). In linear regression analyses, the LV mass index appeared to be lower in patients with RA who were currently receiving corticosteroids (β ± SE −0.082 ± 0.027, P = 0.002), even after adjusting for cardiovascular risk factors and comorbidities.ConclusionRA was strongly associated with abnormal LV remodeling (particularly concentric LV remodeling) among RA patients without heart failure. This association remained significant after adjustment for cardiovascular risk factors and comorbidities. RA disease–related factors may promote changes in LV geometry. The biologic mechanisms underlying LV remodeling warrant further investigation.
Left Ventricular Dysfunction With Pulmonary Hypertension
Georgiopoulou, Vasiliki V., Kalogeropoulos, Andreas P. , Gheorghiade, Mihai , Butler, Javed , Borlaug, Barry A.

Mayo Clinic

Circulation: Heart Failure | March 19, 2013 | Volume: 6 | Issue: 2 | Pages: 344-354

10.1161/circheartfailure.112.000095 | PMID 23513049 Get It

Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting: Is There Any Benefit? A Systematic Review and Meta-Analysis
Shah, Ishan K., Altarabsheh, Salah E. , Erwin, Patricia J., Boilson, Barry A. , Park, Soon J., Joyce, Lyle D., Deo, Salil V. , Dunlay, Shannon M. , Altarabsheh, Salah

Mayo Clinic

Journal of Cardiac Surgery | March 15, 2013 | Volume: 28 | Issue: 2 | Pages: 109-116

10.1111/jocs.12074 | PMID 23488578 Get It

Cardiac Output Response to Exercise in Relation to Metabolic Demand in Heart Failure with Preserved Ejection Fraction
Abudiab, Muaz M. , Redfield, Margaret M. , Melenovský, Vojtěch , Olson, Thomas P. , Johnson, Bruce D. , Kass, David A. , Borlaug, Barry A. , Melenovský, Vojtěch

Mayo Clinic

European Journal of Heart Failure | February 21, 2013 | Volume: 15 | Issue: 7 | Pages: 776-785

10.1093/eurjhf/hft026 | PMID 23426022 Get It

Abstract Aims Exercise intolerance is a hallmark of heart failure with preserved ejection fraction (HFpEF), yet its mechanisms remain unclear. The current study sought to determine whether increases in cardiac output (CO) during exercise are appropriately matched to metabolic demands in HFpEF. Methods and results Patients with HFpEF (n = 109) and controls (n = 73) exercised to volitional fatigue with simultaneous invasive (n = 96) or non-invasive (n = 86) haemodynamic assessment and expired gas analysis to determine oxygen consumption (VO2) during upright or supine exercise. At rest, HFpEF patients had higher LV filling pressures but similar heart rate, stroke volume, EF, and CO. During supine and upright exercise, HFpEF patients displayed lower peak VO2 coupled with blunted increases in heart rate, stroke volume, EF, and CO compared with controls. LV filling pressures increased dramatically in HFpEF patients, with secondary elevation in pulmonary artery pressures. Reduced peak VO2 in HFpEF patients was predominantly attributable to CO limitation, as the slope of the increase in CO relative to VO2 was 20% lower in HFpEF patients (5.9 ± 2.5 vs. 7.4 ± 2.6 L blood/L O2, P = 0.0005). While absolute increases in arterial–venous O2 difference with exercise were similar in HFpEF patients and controls, augmentation in arterial–venous O2 difference relative to VO2 was greater in HFpEF patients (8.9 ± 3.4 vs. 5.5 ± 2.0 min/dL, P < 0.0001). These differences were observed in the total cohort and when upright and supine exercise modalities were examined individually. Conclusion While diastolic dysfunction promotes congestion and pulmonary hypertension with stress in HFpEF, reduction in exercise capacity is predominantly related to inadequate CO relative to metabolic needs.
Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction in Patients With Preserved Ejection Fraction
Ersbøll, Mads , Raja, Anna Axelsson , Gustafsson, Finn , Hassager, Christian , Køber, Lars , Boesgaard, Søren, Skovgaard, Lene Theil , Møller, Jacob Eifer , Andersen, Mads J. , Borlaug, Barry A. , Hassager, Christian , Gustafsson, Finn , Køber, Lars

Mayo Clinic

Circulation | February 14, 2013 | Volume: 127 | Issue: 11 | Pages: 1200-1208

10.1161/circulationaha.112.000056 | PMID 23406672 Get It

Background— Diastolic dysfunction is frequently seen after myocardial infarction and is characterized by a disproportionate increase in filling pressure during exercise to maintain stroke volume. We hypothesized that sildenafil would reduce filling pressure during exercise in patients with diastolic dysfunction after myocardial infarction. Methods and Results— Seventy patients with diastolic dysfunction and near normal left ventricular ejection fraction on echocardiography were randomly assigned sildenafil 40 mg thrice daily or matching placebo for 9 weeks. Before randomization and after 9 weeks of treatment patients underwent simultaneous echocardiography and right heart catheterization at rest and during exercise. Primary end point was pulmonary capillary wedge pressure, and secondary end points comprised cardiac index and pulmonary arterial pressure at rest and during exercise after 9 weeks. After 9 weeks there were no differences in pulmonary capillary wedge pressure at rest (13±4 versus 13±3 mm Hg, P =0.25) or at peak exercise (35±8 mm Hg versus 31±7 mm Hg, P =0.07). However, with treatment cardiac index increased at rest ( P =0.006) and peak exercise ( P =0.02) in the sildenafil group, and systemic vascular resistance index (resting, P =0.0002; peak exercise, P =0.007) and diastolic blood pressure (resting, P =0.005; peak exercise, P =0.02) were lower in the sildenafil group. Resting left ventricular end-diastolic volume index increased ( P =0.001) within the sildenafil group but was unchanged in the placebo group. Conclusions— Sildenafil did not decrease filling pressure at rest or during exercise in post–myocardial infarction patients with diastolic dysfunction. However, there were effects on secondary end points, which require further studies. Clinical Trial Registration— URL: http://www.clinicaltrials.gov/ct2/show/NCT01046838 . Unique identifier: NCT01046838.